{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:03:28Z","timestamp":1790813008543,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11010-021-04299-8","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T13:02:53Z","timestamp":1637240573000},"page":"493-505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Autophagy-associated HMGB-1 as a novel potential circulating non-invasive diagnostic marker for detection of Urothelial Carcinoma of Bladder"],"prefix":"10.1007","volume":"477","author":[{"given":"Aishwarya","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hena","family":"Khandakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amlesh","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7633-9973","authenticated-orcid":false,"given":"Alpana","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"issue":"10061","key":"4299_CR1","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM et al (2016) Bladder cancer. Lancet 388(10061):2796\u20132810. https:\/\/doi.org\/10.1016\/S0140-6736(16)30512-8","journal-title":"Lancet"},{"issue":"6","key":"4299_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA: Cancer J Clin"},{"key":"4299_CR3","doi-asserted-by":"publisher","DOI":"10.12703\/P5-21","author":"ZL Smith","year":"2013","unstructured":"Smith ZL, Guzzo TJ (2013) Urinary markers for bladder cancer. F1000Prime Rep. https:\/\/doi.org\/10.12703\/P5-21","journal-title":"F1000Prime Rep"},{"issue":"11","key":"4299_CR4","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1007\/s00432-019-03024-9","volume":"145","author":"V Anand","year":"2019","unstructured":"Anand V et al (2019) CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt\/ERK\/STAT3 pathways: novel therapeutic approach. J Cancer Res Clin Oncol 145(11):2649\u20132661. https:\/\/doi.org\/10.1007\/s00432-019-03024-9","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1\u20132","key":"4299_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11010-019-03648-y","volume":"464","author":"M Khandelwal","year":"2020","unstructured":"Khandelwal M et al (2020) RASSF1A\u2013hippo pathway link in patients with urothelial carcinoma of bladder: plausible therapeutic target. Mol Cell Biochem 464(1\u20132):51\u201363. https:\/\/doi.org\/10.1007\/s11010-019-03648-y","journal-title":"Mol Cell Biochem"},{"issue":"1\u20132","key":"4299_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11010-018-3278-z","volume":"446","author":"M Khandelwal","year":"2018","unstructured":"Khandelwal M et al (2018) Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1A. Mol Cell Biochem 446(1\u20132):105\u2013114. https:\/\/doi.org\/10.1007\/s11010-018-3278-z","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"4299_CR7","doi-asserted-by":"publisher","first-page":"101042831769911","DOI":"10.1177\/1010428317699112","volume":"39","author":"S Appunni","year":"2017","unstructured":"Appunni S, Anand V, Khandelwal M, Seth A, Mathur S, Sharma A (2017) Altered expression of small leucine-rich proteoglycans (decorin, biglycan and lumican): plausible diagnostic marker in urothelial carcinoma of bladder. Tumour Biol 39(5):101042831769911. https:\/\/doi.org\/10.1177\/1010428317699112","journal-title":"Tumour Biol"},{"issue":"19\u201320","key":"4299_CR8","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.cca.2012.05.005","volume":"413","author":"D Bhagirath","year":"2012","unstructured":"Bhagirath D, Abrol N, Khan R, Sharma M, Seth A, Sharma A (2012) Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder. Clin Chim Acta 413(19\u201320):1641\u20131646. https:\/\/doi.org\/10.1016\/j.cca.2012.05.005","journal-title":"Clin Chim Acta"},{"issue":"5","key":"4299_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3109\/1354750X.2011.582152","volume":"16","author":"A Satyam","year":"2011","unstructured":"Satyam A, Singh P, Sharma M, Seth A, Sharma A (2011) CYFRA 21\u20131: a potential molecular marker for noninvasive differential diagnosis of urothelial carcinoma of bladder. Biomarkers 16(5):413\u2013421. https:\/\/doi.org\/10.3109\/1354750X.2011.582152","journal-title":"Biomarkers"},{"issue":"44","key":"4299_CR10","doi-asserted-by":"publisher","first-page":"1908752","DOI":"10.1002\/adfm.201908752","volume":"30","author":"A Satyam","year":"2020","unstructured":"Satyam A, Tsokos MG, Tresback JS, Zeugolis DI, Tsokos GC (2020) Cell-derived extracellular matrix-rich biomimetic substrate supports podocyte proliferation, differentiation, and maintenance of native phenotype. Adv Funct Mater 30(44):1908752. https:\/\/doi.org\/10.1002\/adfm.201908752","journal-title":"Adv Funct Mater"},{"issue":"22","key":"4299_CR11","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1101\/gad.1599207","volume":"21","author":"N Mizushima","year":"2007","unstructured":"Mizushima N (2007) Autophagy: process and function. Genes Dev 21(22):2861\u20132873. https:\/\/doi.org\/10.1101\/gad.1599207","journal-title":"Genes Dev"},{"issue":"6","key":"4299_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrc3262","volume":"12","author":"E White","year":"2012","unstructured":"White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12(6):401\u2013410. https:\/\/doi.org\/10.1038\/nrc3262","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"4299_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2021.12639","volume":"21","author":"B Zhang","year":"2021","unstructured":"Zhang B, Liu L (2021) Autophagy is a double-edged sword in the therapy of colorectal cancer (review). Oncol Lett 21(5):1\u20138. https:\/\/doi.org\/10.3892\/ol.2021.12639","journal-title":"Oncol Lett"},{"issue":"Suppl 1","key":"4299_CR14","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.4111\/icu.2016.57.S1.S89","volume":"57","author":"T Chandrasekar","year":"2016","unstructured":"Chandrasekar T, Evans CP (2016) Autophagy and urothelial carcinoma of the bladder: a review. Investig Clin Urol 57(Suppl 1):S89. https:\/\/doi.org\/10.4111\/icu.2016.57.S1.S89","journal-title":"Investig Clin Urol"},{"issue":"3","key":"4299_CR15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/1535370220959336","volume":"246","author":"E Konac","year":"2021","unstructured":"Konac E, Kurman Y, Baltaci S (2021) Contrast effects of autophagy in the treatment of bladder cancer. Exp Biol Med (Maywood) 246(3):354\u2013367. https:\/\/doi.org\/10.1177\/1535370220959336","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1\u20132","key":"4299_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbagrm.2009.11.014","volume":"1799","author":"D Tang","year":"2010","unstructured":"Tang D, Kang R, Zeh HJ, Lotze MT (2010) High-mobility group box 1 [HMGB1] and cancer. Biochim Biophys Acta 1799(1\u20132):131. https:\/\/doi.org\/10.1016\/j.bbagrm.2009.11.014","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"4299_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1083\/jcb.200911078","volume":"190","author":"D Tang","year":"2010","unstructured":"Tang D et al (2010) Endogenous HMGB1 regulates autophagy. J Cell Biol 190(5):881\u2013892. https:\/\/doi.org\/10.1083\/jcb.200911078","journal-title":"J Cell Biol"},{"issue":"38","key":"4299_CR18","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1038\/onc.2010.261","volume":"29","author":"D Tang","year":"2010","unstructured":"Tang D et al (2010) HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 29(38):5299\u20135310. https:\/\/doi.org\/10.1038\/onc.2010.261","journal-title":"Oncogene"},{"issue":"1","key":"4299_CR19","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1146\/annurev-biochem-060815-014556","volume":"85","author":"CF Bento","year":"2016","unstructured":"Bento CF et al (2016) Mammalian autophagy: how does it work? Annu Rev Biochem 85(1):685\u2013713. https:\/\/doi.org\/10.1146\/annurev-biochem-060815-014556","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"4299_CR20","doi-asserted-by":"publisher","first-page":"12807","DOI":"10.1038\/srep12807","volume":"5","author":"Z Huang","year":"2015","unstructured":"Huang Z et al (2015) Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-\u03baB pathway. Sci Rep 5(1):12807. https:\/\/doi.org\/10.1038\/srep12807","journal-title":"Sci Rep"},{"issue":"1","key":"4299_CR21","doi-asserted-by":"publisher","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","volume":"3","author":"O Sanli","year":"2017","unstructured":"Sanli O et al (2017) Bladder cancer. Nat Rev Dis Primers 3(1):17022. https:\/\/doi.org\/10.1038\/nrdp.2017.22","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"4299_CR22","doi-asserted-by":"publisher","first-page":"e13752","DOI":"10.1111\/ijcp.13752","volume":"75","author":"S Akan","year":"2021","unstructured":"Akan S, Ediz C, K\u0131z\u0131lkan YE, Alcin A, Tavukcu HH, Yilmaz O (2021) COVID-19 infection threat in patients with high-risk non-muscle invasive bladder cancer receiving intravesical BCG therapy. Int J Clin Pract 75(3):e13752. https:\/\/doi.org\/10.1111\/ijcp.13752","journal-title":"Int J Clin Pract"},{"key":"4299_CR23","doi-asserted-by":"publisher","first-page":"108795","DOI":"10.1016\/j.clim.2021.108795","volume":"229","author":"S Jamaly","year":"2021","unstructured":"Jamaly S et al (2021) Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19. Clin Immunol 229:108795. https:\/\/doi.org\/10.1016\/j.clim.2021.108795","journal-title":"Clin Immunol"},{"key":"4299_CR24","doi-asserted-by":"publisher","first-page":"108603","DOI":"10.1016\/j.clim.2020.108603","volume":"221","author":"A Satyam","year":"2020","unstructured":"Satyam A, Tsokos GC (2020) Curb complement to cure COVID-19. Clin Immunol 221:108603. https:\/\/doi.org\/10.1016\/j.clim.2020.108603","journal-title":"Clin Immunol"},{"key":"4299_CR25","doi-asserted-by":"publisher","first-page":"108716","DOI":"10.1016\/j.clim.2021.108716","volume":"226","author":"A Satyam","year":"2021","unstructured":"Satyam A, Tsokos MG, Brook OR, Hecht JL, Moulton VR, Tsokos GC (2021) Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19. Clin Immunol 226:108716. https:\/\/doi.org\/10.1016\/j.clim.2021.108716","journal-title":"Clin Immunol"},{"issue":"4","key":"4299_CR26","doi-asserted-by":"publisher","first-page":"e34318","DOI":"10.1371\/journal.pone.0034318","volume":"7","author":"H Lee","year":"2012","unstructured":"Lee H et al (2012) Diagnostic significance of serum HMGB1 in colorectal carcinomas. PLoS ONE 7(4):e34318. https:\/\/doi.org\/10.1371\/journal.pone.0034318","journal-title":"PLoS ONE"},{"issue":"4","key":"4299_CR27","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3892\/or.2015.3782","volume":"33","author":"Q-Y Zhang","year":"2015","unstructured":"Zhang Q-Y, Wu L-Q, Zhang T, Han Y-F, Lin X (2015) Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1\/2. Oncol Rep 33(4):1630\u20131638. https:\/\/doi.org\/10.3892\/or.2015.3782","journal-title":"Oncol Rep"},{"issue":"3","key":"4299_CR28","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3892\/ol.2012.1091","volume":"5","author":"W Wang","year":"2013","unstructured":"Wang W et al (2013) Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma. Oncol Lett 5(3):884\u2013888. https:\/\/doi.org\/10.3892\/ol.2012.1091","journal-title":"Oncol Lett"},{"issue":"8","key":"4299_CR29","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/labinvest.2009.47","volume":"89","author":"HJ Kang","year":"2009","unstructured":"Kang HJ et al (2009) Non-histone nuclear factor HMGB1 is phosphorylated and secreted in colon cancers. Lab Investig 89(8):948\u2013959. https:\/\/doi.org\/10.1038\/labinvest.2009.47","journal-title":"Lab Investig"},{"issue":"4","key":"4299_CR30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mc.22944","volume":"58","author":"F Qian","year":"2019","unstructured":"Qian F, Xiao J, Gai L, Zhu J (2019) HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development. Mol Carcinog 58(4):500\u2013510. https:\/\/doi.org\/10.1002\/mc.22944","journal-title":"Mol Carcinog"},{"issue":"7","key":"4299_CR31","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.7314\/apjcp.2015.16.7.2725","volume":"16","author":"H Khorramdelazad","year":"2015","unstructured":"Khorramdelazad H et al (2015) S100A12 and RAGE expression in human bladder transitional cell carcinoma: a role for the ligand\/RAGE axis in tumor progression? Asian Pac J Cancer Prev 16(7):2725\u20132729. https:\/\/doi.org\/10.7314\/apjcp.2015.16.7.2725","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"4299_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5301\/JBM.2012.9769","volume":"28","author":"G Liu","year":"2013","unstructured":"Liu G et al (2013) Expression of beclin 1 in bladder cancer and its clinical significance. Int J Biol Markers 28(1):56\u201362. https:\/\/doi.org\/10.5301\/JBM.2012.9769","journal-title":"Int J Biol Markers"},{"issue":"7","key":"4299_CR33","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.prp.2013.04.006","volume":"209","author":"S Baspinar","year":"2013","unstructured":"Baspinar S, Bircan S, Yavuz G, Kapucuoglu N (2013) Beclin 1 and bcl-2 expressions in bladder urothelial tumors and their association with clinicopathological parameters. Pathol Res Pract 209(7):418\u2013423. https:\/\/doi.org\/10.1016\/j.prp.2013.04.006","journal-title":"Pathol Res Pract"},{"issue":"4","key":"4299_CR34","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.3390\/ijms15045292","volume":"15","author":"M Cai","year":"2014","unstructured":"Cai M et al (2014) Beclin 1 expression in ovarian tissues and its effects on ovarian cancer prognosis. IJMS 15(4):5292\u20135303. https:\/\/doi.org\/10.3390\/ijms15045292","journal-title":"IJMS"},{"issue":"4","key":"4299_CR35","first-page":"3882","volume":"8","author":"S Wu","year":"2015","unstructured":"Wu S et al (2015) Expression and clinical significances of beclin1, LC3 and mTOR in colorectal cancer. Int J Clin Exp Pathol 8(4):3882\u20133891","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"4299_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-021-00538-5","volume":"7","author":"F Shi","year":"2021","unstructured":"Shi F, Luo D, Zhou X, Sun Q, Shen P, Wang S (2021) Combined effects of hyperthermia and chemotherapy on the regulate autophagy of oral squamous cell carcinoma cells under a hypoxic microenvironment. Cell Death Discov 7(1):1\u201312. https:\/\/doi.org\/10.1038\/s41420-021-00538-5","journal-title":"Cell Death Discov"},{"issue":"4","key":"4299_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/1346-8138.12439","volume":"41","author":"N Yoshihara","year":"2014","unstructured":"Yoshihara N, Takagi A, Ueno T, Ikeda S (2014) Inverse correlation between microtubule-associated protein 1A\/1B-light chain 3 and p62\/sequestosome-1 expression in the progression of cutaneous squamous cell carcinoma. J Dermatol 41(4):311\u2013315. https:\/\/doi.org\/10.1111\/1346-8138.12439","journal-title":"J Dermatol"},{"key":"4299_CR38","doi-asserted-by":"publisher","unstructured":"Arani RH, Mohammadpour H, Moosavi MA, Abdollahi A, Rahmati M (2021) Autophagy markers p62, LC3II and beclin1 correlate with clark levels in melanoma tumors. Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-727631\/v1","DOI":"10.21203\/rs.3.rs-727631\/v1"},{"issue":"6","key":"4299_CR39","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.juro.2014.01.006","volume":"191","author":"R Ojha","year":"2014","unstructured":"Ojha R et al (2014) Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent. J Urol 191(6):1889\u20131898. https:\/\/doi.org\/10.1016\/j.juro.2014.01.006","journal-title":"J Urol"},{"issue":"4","key":"4299_CR40","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/cas.14321","volume":"111","author":"T Li","year":"2020","unstructured":"Li T, Jiang D, Wu K (2020) p62 promotes bladder cancer cell growth by activating KEAP1\/NRF2-dependent antioxidative response. Cancer Sci 111(4):1156\u20131164. https:\/\/doi.org\/10.1111\/cas.14321","journal-title":"Cancer Sci"},{"key":"4299_CR41","doi-asserted-by":"publisher","unstructured":"Lai W, Kong Q, Chen H, Li X, Li Y, Fang J (2021) Extracellular HMGB1 interacts with RAGE and promotes chemoresistance in acute leukemia cell. Europe PMC. https:\/\/doi.org\/10.21203\/rs.3.rs-349396\/v1","DOI":"10.21203\/rs.3.rs-349396\/v1"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04299-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-021-04299-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04299-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T08:11:48Z","timestamp":1744099908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-021-04299-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["4299"],"URL":"https:\/\/doi.org\/10.1007\/s11010-021-04299-8","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"assertion":[{"value":"12 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research involving human patients and healthy individuals had provided written informed consent. This study has been approved by Institutional Human Ethics Committee of All India Institute of Medical Sciences, New Delhi, India (IECPG-692\/31.01.2018) prior to its commencement.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}